MedPath

Nextrast Inc

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

Safety Study of CZ10 in Healthy Volunteers

Phase 1
Not yet recruiting
Conditions
Healthy Volunteer Study
Interventions
Drug: Contrast Media
Drug: Placebo
First Posted Date
2024-11-27
Last Posted Date
2024-11-29
Lead Sponsor
Nextrast, Inc.
Target Recruit Count
24
Registration Number
NCT06708767

Phase 2 Study of NX9 for Delineation of Bowel Anatomy

Phase 2
Completed
Conditions
GI Carcinoma
GI Disorders
Interventions
First Posted Date
2021-03-09
Last Posted Date
2022-01-18
Lead Sponsor
Nextrast, Inc.
Target Recruit Count
32
Registration Number
NCT04789200
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

🇺🇸

University of Washington, Seattle, Washington, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.